In summary, our meta-analysis demonstrated altered IL-6, TNF-α, IL-1β, MCP-1 and CRP levels in both peripheral blood and CSF in PD patients versus control groups, and altered IL-4, IFN-γ, STNFR1 and fractalkine only in blood. This evidence concerns the gene IL1B and Parkinson disease.